Who Should Not Take Peptides: Contraindications and Safety Guide

Critical Preface

This article discusses safety considerations for peptides. Most peptides mentioned are either:

• Research compounds not approved for human use
• Prescription medications requiring medical supervision

Self-administration without medical guidance carries significant risks. This information is educational, not permission or guidance for use.

Table of Contents

1. General Contraindications
2. GLP-1 Agonist Contraindications
3. Growth Hormone Peptide Contraindications
4. Healing Peptide Considerations
5. Drug Interactions
6. Special Populations
7. Signs to Stop Use
8. Frequently Asked Questions
9. Conclusion

General Contraindications

Who Should Avoid Peptides Generally

Pregnancy and Breastfeeding

Nearly all peptides are contraindicated:

Exception: Some FDA-approved peptides have specific pregnancy categories—follow prescribing information.

Cancer Considerations

High-Risk Peptides:

• Growth hormone secretagogues
• IGF-1 related peptides
• Any growth factor peptides

Why:

• IGF-1 promotes cell growth
• May affect tumor progression
• Theoretical but significant concern

Who Should Avoid:

• Active cancer of any type
• History of hormone-sensitive cancers
• Family history of certain cancers (discuss with oncologist)

GLP-1 Agonist Contraindications

FDA-Approved GLP-1s (Semaglutide, Tirzepatide)

Absolute Contraindications:

Medullary Thyroid Carcinoma (MTC)

Black Box Warning:

• Animal studies showed thyroid tumors
• Unknown if this translates to humans
• Anyone with personal/family MTC history should NOT use

Relative Contraindications

Drug Interactions

Growth Hormone Peptide Contraindications

GH Secretagogues (CJC-1295, Ipamorelin, MK-677, etc.)

Note: These are research compounds without FDA approval

Who Should Avoid:

Cancer Concerns with GH Peptides

Growth hormone increases IGF-1:

• IGF-1 promotes cell proliferation
• May affect tumor growth
• Theoretical but significant risk
• Most oncologists advise against

Who Should Absolutely Avoid:

• Any active malignancy
• History of:
  • Breast cancer
  • Prostate cancer
  • Colon cancer
  • Any cancer (discuss with oncologist)

Diabetes and GH Peptides

Other GH Peptide Contraindications

Healing Peptide Considerations

BPC-157 and TB-500

Important: These are research compounds with limited safety data

Potential Concerns (Theoretical):

Cancer and Healing Peptides

Angiogenesis Concern:

• BPC-157 promotes blood vessel formation
• Tumors require blood supply
• Theoretical promotion of tumor growth
• No direct evidence but logical concern

Recommendation:

• Active cancer: Avoid
• Cancer history: Discuss with oncologist
• Cancer risk: Consider carefully

Autoimmune Considerations

TB-500 (Thymosin Beta-4) has immune effects:

• May modulate immune function
• Unpredictable in autoimmune disease
• Could theoretically worsen or improve
• Caution advised

Drug Interactions

Important Interactions by Peptide Type

GLP-1 Agonists

GH Peptides

General Peptide Concerns

Special Populations

Elderly

Adolescents and Children

Generally contraindicated:

• Growth effects during development
• Hormonal disruption
• Unknown long-term effects
• No pediatric safety data (for most)

Athletes

Liver Disease

Kidney Disease

Signs to Stop Use

Immediate Stop Signs

Stop immediately and seek medical attention for:

Concerning Signs

Consult healthcare provider for:

Monitoring Recommendations

Frequently Asked Questions

Can I take peptides with diabetes?

GLP-1 agonists are actually diabetes treatments, but require medical supervision due to hypoglycemia risk. GH peptides can worsen glucose control. Medical guidance essential.

Are peptides safe if I've had cancer?

Most peptide experts recommend avoiding growth factor-related peptides with cancer history. This includes GH secretagogues and potentially BPC-157/TB-500. Consult your oncologist.

Can I use peptides before surgery?

Stop most peptides 1-2 weeks before surgery. GH peptides affect healing and blood sugar. GLP-1s affect anesthesia. Discuss with your surgeon.

Are peptides safe with heart conditions?

Depends on the condition and peptide. GLP-1s may have cardiovascular benefits. GH peptides cause fluid retention. Medical supervision required.

Can I use research peptides safely?

"Research peptides" are not approved for human use. They carry additional risks of purity, contamination, and unknown effects. Safety cannot be assured.

What about peptides during pregnancy planning?

Stop all non-essential peptides when planning pregnancy. Effects on fertility and early pregnancy unknown for most peptides.

Conclusion

Peptides are not universally safe, and many people should avoid them entirely or use them only under strict medical supervision.

Key Takeaways

Final Warnings

1. Research peptides are not medications - no guaranteed safety
2. FDA-approved peptides require prescriptions - for good reason
3. Self-treatment is risky - unknown interactions and effects
4. Medical supervision is essential - even for "safe" peptides
5. When in doubt, don't - the safest peptide is no peptide

Peptides should only be used with appropriate medical guidance, full understanding of risks, and honest assessment of whether benefits outweigh potential harms.

References

1. FDA Prescribing Information. Semaglutide (Ozempic/Wegovy).

2. FDA Prescribing Information. Tirzepatide (Mounjaro/Zepbound).

3. Melmed S. Pituitary-Tumor Endocrinopathies. N Engl J Med. 2020.

4. GLP-1 receptor agonist contraindications. UpToDate. 2024.

5. Growth hormone safety and contraindications. Endocr Rev. 2019.

6. Peptide drug interactions database. Clinical Pharmacology. 2024.